Wednesday, June 1, 2016

Imaging biomarker distinguishes prostate cancer tumor grade

Physicians have long used magnetic resonance imaging (MRI) to detect cancer, but results of a new study describe the potential use of restriction spectrum imaging (RSI) as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment and biopsy.



from Top Health News – ScienceDaily http://bit.ly/1Uht5j7 via Naturally Increase Breast Size At Home
from Tumblr http://bit.ly/1t1K1EF

No comments:

Post a Comment